Assenagon Asset Management S.A. Makes New Investment in HealthEquity, Inc. $HQY

Key Points

• Assenagon Asset Management initiated a HealthEquity position of 21,215 shares valued at approximately $1.9 million. Institutional investors collectively own 99.55% of the company.
• HealthEquity exceeded quarterly expectations, reporting $1.24 in EPS versus the $1.11 consensus and revenue of $354.64 million, up 7.2% year over year.
• Analysts maintain a broadly positive outlook, with a “Moderate Buy” consensus rating and an average price target of $110.93, while insiders sold 17,905 shares worth approximately $1.65 million during the past quarter.

Assenagon Asset Management S.A. bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 21,215 shares of the company's stock, valued at approximately $1,916,000.

Other hedge funds also recently bought and sold shares of the company. Oxbow Advisors LLC bought a new stake in HealthEquity during the first quarter worth approximately $3,147,000. Westfield Capital Management Co. LP raised its position in HealthEquity by 13.7% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company's stock valued at $178,864,000 after purchasing an additional 235,794 shares during the period. Norges Bank bought a new stake in shares of HealthEquity in the 4th quarter valued at approximately $66,927,000. Sumitomo Mitsui DS Asset Management Company Ltd bought a new stake in shares of HealthEquity in the 4th quarter valued at approximately $4,381,000. Finally, Future Fund LLC boosted its holdings in shares of HealthEquity by 40.9% in the 4th quarter. Future Fund LLC now owns 44,317 shares of the company's stock worth $4,060,000 after purchasing an additional 12,854 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Trading Up 0.1%

Shares of HQY opened at $105.59 on Friday. The firm has a market capitalization of $8.83 billion, a price-to-earnings ratio of 39.55, a PEG ratio of 1.77 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The company has a 50-day moving average of $94.83 and a 200 day moving average of $86.38.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity's quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Citigroup reissued a "market outperform" rating on shares of HealthEquity in a research report on Monday, June 1st. Citizens Jmp raised their price target on HealthEquity from $110.00 to $111.00 and gave the stock a "market outperform" rating in a research report on Monday, June 1st. Royal Bank Of Canada lifted their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 3rd. Barrington Research reissued an "outperform" rating and issued a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. Finally, BTIG Research increased their target price on shares of HealthEquity from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, July 24th. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $110.93.

Insider Buying and Selling

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the company's stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the company's stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares of the company's stock, valued at $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock valued at $1,651,280 over the last quarter. 1.60% of the stock is owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source